Acadian Asset Management LLC Astrazeneca PLC Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Acadian Asset Management LLC holds 516,177 shares of AZN stock, worth $34.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

516,177

Previous 11,525 4378.76%

Holding current value

$34.5 Million

Previous $897,000 4381.16%

% of portfolio

0.12%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $38.7 Million - $44.2 Million	504,652 Added 4378.76%	516,177 $40.2 Million
Q2 2024 Aug 06, 2024	SELL	$66.81 - $80.83 $53,982 - $65,310	-808 Reduced 6.55%	11,525 $897,000
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $849,964 - $968,901	-13,927 Reduced 53.04%	12,333 $834,000
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $838,733 - $938,882	-13,552 Reduced 34.04%	26,260 $1.77 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $5.61 Million - $6.2 Million	-86,442 Reduced 68.47%	39,812 $2.69 Million
Q2 2023 Aug 07, 2023	BUY	$69.91 - $75.81 $6.45 Million - $7 Million	92,277 Added 271.59%	126,254 $9.03 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $1.54 Million - $1.75 Million	-24,444 Reduced 41.84%	33,977 $2.35 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $2.11 Million - $2.74 Million	38,912 Added 199.46%	58,421 $3.96 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $801,927 - $2.05 Million	15,125 Added 345.0%	19,509 $1.07 Million
Q2 2022 Aug 09, 2022	BUY	$59.26 - $71.14 $228,802 - $274,671	3,861 Added 738.24%	4,384 $289,000
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $1.22 Million - $1.47 Million	-21,916 Reduced 97.67%	523 $34,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $3.01 Million - $3.56 Million	-55,741 Reduced 71.3%	22,439 $1.31 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $3.91 Million - $4.28 Million	-70,329 Reduced 47.36%	78,180 $4.69 Million
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $2.41 Million - $2.99 Million	-49,741 Reduced 25.09%	148,509 $8.9 Million
Q1 2021 May 11, 2021	SELL	$47.16 - $54.44 $7.12 Million - $8.22 Million	-151,015 Reduced 43.24%	198,250 $9.86 Million
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $5.64 Million - $6.74 Million	116,244 Added 49.89%	349,265 $17.5 Million
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $12.4 Million - $14.2 Million	233,021 New	233,021 $12.8 Million
Q3 2018 Oct 30, 2018	SELL	$34.76 - $39.72 $75,151 - $85,874	-2,162 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$34.55 - $37.05 $110,974 - $119,004	-3,212 Reduced 59.77%	2,162 $76,000
Q1 2018 Apr 12, 2018	SELL	$32.97 - $36.63 $19.9 Million - $22.1 Million	-602,290 Reduced 99.12%	5,374 $188,000
Q4 2017 Jan 18, 2018	SELL	$32.09 - $34.78 $23.1 Million - $25.1 Million	-720,513 Reduced 54.25%	607,664 $21.1 Million
Q3 2017 Oct 13, 2017	BUY	$28.96 - $34.0 $38.5 Million - $45.2 Million	1,328,177	1,328,177 $45 Million

Others Institutions Holding AZN

# of Institutions

1,354

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Astrazeneca PLC Transaction History